X-ray-induced Acoustic Computed Tomography (XACT) for In Vivo Dosimetry
Tech ID: 34113 / UC Case 2021-729-0
Brief Description
This technology leverages X-ray-induced acoustic phenomena for real-time, in-line verification of photon beam location and dose during cancer radiotherapy.
Full Description
X-ray-induced Acoustic Computed Tomography (XACT) utilizes the conversion of X-rays to acoustic waves through thermoelastic expansion, enabling the imaging of acoustic waves generated by X-ray absorption in tissues. This process allows for the monitoring of radiation dose and beam alignment during radiotherapy, ensuring precise targeting and dose delivery to cancerous tissues.
Suggested uses
- Real-time dosimetry in radiotherapy for cancer treatment.
- Enhancement of precision in radiation therapy through in-line verification.
- Integration into existing radiotherapy equipment to improve treatment outcomes.
- Development of new radiotherapy devices with built-in XACT technology.
Advantages
- Real-time monitoring of radiation dose and beam location.
- Non-invasive in vivo dosimetry for enhanced treatment safety.
- Ability to detect geometric and morphological misalignments of the X-ray field.
- Improves the precision and effectiveness of radiotherapy treatments.
- Linear correlation between acoustic signal strength and X-ray dose deposition for accurate dosimetry.
Patent Status
Patent Cooperation Treaty |
Reference for National Filings |
WO 2022/081763 |
04/21/2022 |
2021-729 |
|
|
Patent Pending